Pharmacological inhibition of histone deacetylase 6 and DNA damage repair enhances radiosensitivity in melanoma

Key Points

• Radiosensitivity is significantly increased when histone deacetylase 6 is inhibited alongside DNA damage repair.
• Results show enhanced radiosensitivity, indicating a potential for improved cancer treatment outcomes.
• Assessment using pharmacological agents reveals important implications for targeting melanoma tumors.
• Combining these treatments may lead to better therapeutic strategies, although clinical validation is necessary.